A Mount Sinai team showed that the same leukemia mutation behaves differently depending on when it arises during development.
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
In cooperation with universities, the Center of Estonian Rural Research and Knowledge (METK) is leading a project aimed at ...
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
In recent years, there has been a dramatic rise of innovation in human genomic technology. This has been most notably seen in new and effective genomic ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Sofi-cel is an investigational, potential first-in-class, allogeneic, anti-CD7 CAR-T cell therapy currently under evaluation in a pivotal trial (T-RRex) for patients with relapsed or refractory (R/R) ...
Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.
MedPage Today on MSN
Gene Therapy Also Effective in Younger Children With Inherited Blood Disorders
Exa-cel could provide benefit before kids develop chronic organ damage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback